StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen total Product Sales — Worldwide ($M) ($M)

Form 10-Q / 10-K Consolidated Statements of Income & Form 8-K Product Sales Detail

Latest, FY2025
35,148
Period ended Dec 31, 2025
Change on a year earlier
+9.7%
32,026 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Product Sales — Worldwide ($M) ($M)Year on yearSource
FY2025Dec 31, 202535,148+9.7%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202432,026+19.0%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 202326,910+8.5%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 202224,801+2.1%Form 10-K (filed 2025-02-14) ↗
FY2021Dec 31, 202124,297+0.2%Form 10-K (filed 2024-02-14) ↗
FY2020Dec 31, 202024,240+9.2%Form 10-K (filed 2023-02-09) ↗
FY2019Dec 31, 201922,204-1.5%Form 10-K (filed 2022-02-16) ↗
FY2018Dec 31, 201822,533+3.4%Form 10-K (filed 2021-02-09) ↗
FY2017Dec 31, 201721,795-0.4%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 201621,892+4.5%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 201520,944–Form 10-K (filed 2018-02-13) ↗

Breakdown

What makes up total product sales — worldwide ($m)

Cite this data

StockData. (2026). Amgen Total Product Sales — Worldwide ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod_total_ww

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.